学术探索
学术期刊
新闻热点
数据分析
智能评审

Targeting VEGF in cancer therapy

被引：26
作者：
不详
机构：
来源：
CURRENT PROBLEMS IN CANCER | 2006年 / 30卷 / 01期
关键词：
D O I：
10.1016/j.currproblcancer.2005.11.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 32
页数：26
相关论文
共 99 条
[41]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342
[42]  
HURWITZ H, 2002, P AN M AM SOC CLIN, pA325
[43]   Bevacizurnab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer [J].
Hurwitz, HI ;
Fehrenbacher, L ;
Hainsworth, JD ;
Heim, W ;
Berlin, J ;
Holmgren, E ;
Hambleton, J ;
Novotny, WF ;
Kabbinavar, F .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3502-3508
[44]   Negative regulation of hypoxia-inducible genes by the von Hippel Lindau protein [J].
Iliopoulos, O ;
Levy, AP ;
Jiang, C ;
Kaelin, WG ;
Goldberg, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10595-10599
[45]   Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer [J].
Johnson, DH ;
Fehrenbacher, L ;
Novotny, WF ;
Herbst, RS ;
Nemunaitis, JJ ;
Jablons, DM ;
Langer, CJ ;
DeVore, RF ;
Gaudreault, J ;
Damico, LA ;
Holmgren, E ;
Kabbinavar, F .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2184-2191
[46]   Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer [J].
Kabbinavar, F ;
Hurwitz, HI ;
Fehrenbacher, L ;
Meropol, NJ ;
Novotny, WF ;
Lieberman, G ;
Griffing, S ;
Bergsland, E .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :60-65
[47]   Addition of bevacizurnab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: Results of a randomized phase II trial [J].
Kabbinavar, FF ;
Schulz, J ;
McCleod, M ;
Patel, T ;
Hamm, JT ;
Hecht, JR ;
Mass, R ;
Perrou, B ;
Nelson, B ;
Novotny, WF .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3697-3705
[48]   Combined analysis of efficacy: The addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer [J].
Kabbinavar, FF ;
Hambleton, J ;
Mass, RD ;
Hurwitz, HL ;
Bergsland, E ;
Sarkar, S .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3706-3712
[49]  
Klem Jennifer, 2003, Clin Colorectal Cancer, V3, P147
[50]  
Konner Jason, 2004, Clin Colorectal Cancer, V4 Suppl 2, pS81
12345678910